Cardiogenic shock (CS) is a situation of low cardiac output that is associated with hypoperfusion and multisystemic organ failure. The most common cause is acute myocardial infarction with severe left ventricular dysfunction. Advances in reperfusion therapy have improved CS survival, but in-hospital mortality remains high (around 50%). Coordinated regional health care systems, associated with common treatment algorithms, have improved survival in severe acute conditions in which the prognosis is time-dependent (acute myocardial infarction [AMI], stroke, outpatient cardiac arrest, polytrauma). Applying a similar strategy adapted to the CS could have a similar effect on its survival.
Cardiogenic shock; Treatment; Via xoc;
Perez Villa F, Ariza A, Campreciós M, Jacob X, Manito N, Morales JA, et al .Recomanacions per a l’organització del tractament del xoc cardiogènic a Catalunya: via xoc. Barcelona: Servei Català de la Salut; 2021.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/6187
This item appears in following collections
The following license files are associated with this item: